Document is current
Any future updates will be listed below
-
Authors
Haram, Marit https://orcid.org/0000-0001-9141-1857
Jangmo, Andreas
Jaholkowski, Piotr
Pasman, Joëlle
Meijsen, Joeri https://orcid.org/0000-0002-4161-2199
Shorter, John R.
Corfield, Elizabeth C. https://orcid.org/0000-0002-0119-157X
Frei, Oleksandr https://orcid.org/0000-0002-6427-2625
Reichborn-Kjennerud, Ted https://orcid.org/0000-0003-4653-0034
Buil, Alfonso https://orcid.org/0000-0002-3097-1014
Lu, Yi https://orcid.org/0000-0001-9933-3654
Werge, Thomas https://orcid.org/0000-0003-1829-0766
Sullivan, Patrick https://orcid.org/0000-0002-6619-873X
Andreassen, Ole A. https://orcid.org/0000-0002-4461-3568
Tesli, Martin https://orcid.org/0000-0001-7495-5545
- License Information
-
More Information
Article History
Received: 5 November 2024
Revised: 24 July 2025
Accepted: 5 September 2025
First Online: 17 September 2025
Competing interests
: MH and MT have served as a speakers for Lundbeck. PFS is a consultant and shareholder of Neumora Therapeutics. OF is a consultant for Precision Health. OAA is consultant for Cortechs.ai and Precision Health, and has received speaker’s honorarium from Lundbeck, Janssen, Otsuka and Sunovion.
